Adjuvant Archives

Strong Impact of MammaPrint and BluePrint on Treatment Decisions in Luminal Early Breast Cancer: Results of the WSG-PRIMe Study
Gallery
Strong Impact of MammaPrint and BluePrint on Treatment Decisions in Luminal Early Breast Cancer: Results of the WSG-PRIMe Study

Adjuvant, BluePrint, Evidence, MammaPrint, WSG-PRIMe

Strong Impact of MammaPrint and BluePrint on Treatment Decisions in Luminal Early Breast Cancer: Results of the WSG-PRIMe Study

PUBLICATION: Breast Cancer Res Treat. (2019) 175: 389. https://doi.org/10.1007/s10549-018-05075-x. AUTHORS: Read More

kevin2024-03-25T11:24:02-07:00June 1st, 2019|Adjuvant, BluePrint, Evidence, MammaPrint, WSG-PRIMe|

Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay
Gallery
Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

Adjuvant, Evidence, MammaPrint, PROMIS

Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

PUBLICATION: JAMA Oncol. 2018; 4(1):e173470. doi:10.1001/jamaoncol.2017.3470. AUTHORS: Michaela Tsai, MD; Read More

kevin2024-03-25T08:57:37-07:00January 11th, 2018|Adjuvant, Evidence, MammaPrint, PROMIS|

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study
Gallery
Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

Adjuvant, Evidence, MammaPrint

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

PUBLICATION: Journal of Clinical Oncology 35, no. 24 (August 20, Read More

kevin2024-03-25T09:02:54-07:00August 20th, 2017|Adjuvant, Evidence, MammaPrint|

Characterisation of Multifocal Breast Cancer Using the 70-gene Signature in Clinical Low-Risk Patients Enrolled in the EORTC 10041/BIG 03-04 MINDACT Trial.
Gallery
Characterisation of Multifocal Breast Cancer Using the 70-gene Signature in Clinical Low-Risk Patients Enrolled in the EORTC 10041/BIG 03-04 MINDACT Trial.

Adjuvant, Evidence, MammaPrint, MINDACT

Characterisation of Multifocal Breast Cancer Using the 70-gene Signature in Clinical Low-Risk Patients Enrolled in the EORTC 10041/BIG 03-04 MINDACT Trial.

PUBLICATION: European Journal of Cancer. July 2017, Volume 79, Pages Read More

kevin2024-03-25T09:03:49-07:00July 2nd, 2017|Adjuvant, Evidence, MammaPrint, MINDACT|

A Breast Cancer Gene Signature for Indolent Disease
Gallery
A Breast Cancer Gene Signature for Indolent Disease

Adjuvant, Evidence, MammaPrint, RASTER

A Breast Cancer Gene Signature for Indolent Disease

PUBLICATION: Breast Cancer Res Treat. 2017 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub Read More

kevin2024-03-25T09:05:40-07:00July 1st, 2017|Adjuvant, Evidence, MammaPrint, RASTER|

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Gallery
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

Adjuvant, Evidence, MammaPrint, MINDACT

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

PUBLICATION: N Engl J Med 2016; 375:717-729; DOI: 10.1056/NEJMoa1602253. AUTHORS: Read More

kevin2024-03-25T09:18:22-07:00August 25th, 2016|Adjuvant, Evidence, MammaPrint, MINDACT|

MINDACT Supplementary Appendix NEJM 2016
Gallery
MINDACT Supplementary Appendix NEJM 2016

Adjuvant, Evidence, MammaPrint, MINDACT

MINDACT Supplementary Appendix NEJM 2016

SUPPLEMENTARY APPENDIX: This appendix has been provided by the authors Read More

kevin2024-03-25T09:18:44-07:00August 15th, 2016|Adjuvant, Evidence, MammaPrint, MINDACT|

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis
Gallery
Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

Adjuvant, Evidence, MammaPrint

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

PUBLICATION: Breast Cancer Res Treat (2014) 148: 599. https://doi.org/10.1007/s10549-014-3188-z. AUTHORS: Read More

kevin2024-03-25T09:27:24-07:00November 24th, 2014|Adjuvant, Evidence, MammaPrint|

The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer
Gallery
The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

Adjuvant, Evidence, MammaPrint

The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

PUBLICATION: British Journal of Cancer, volume 111, pages 837–842 (26 Read More

kevin2024-03-25T10:20:39-07:00August 26th, 2014|Adjuvant, Evidence, MammaPrint|

European Inter-Institutional Impact Study of MammaPrint
Gallery
European Inter-Institutional Impact Study of MammaPrint

Adjuvant, Evidence, MammaPrint

European Inter-Institutional Impact Study of MammaPrint

PUBLICATION: The Breast August 2014, Volume 23, Issue 4, Pages Read More

kevin2024-03-25T10:07:03-07:00August 1st, 2014|Adjuvant, Evidence, MammaPrint|